Background The impact of high-dose therapy and autologous stem cell transplantation
(ASCT) vs conventional-dose chemotherapy in the initial management of adults with …

Treatment options for follicular lymphoma have expanded dramatically. The most important
relate to the introduction of monoclonal antibodies and the completion of important studies …

The role of autologous stem cell transplantation (ASCT) and the optimal timing of such
transplants in patients with follicular lymphoma (FL) remains contentious. We present a …

High-dose chemotherapy supported by autologous stem cell transplantation (HDT/ASCT)
has contributed to modify the natural history of follicular lymphoma (FL); however, an overall …

Follicular non-Hodgkin's lymphomas usually present in advanced stage and although
frequently are chemotherapy-sensitive remain incurable using conventional approaches …

Autologous stem cell transplantation (ASCT) as first-line therapy for follicular lymphoma (FL)
remains controversial. The multicenter study randomized 172 patients with untreated FL for …

Background Follicular lymphoma (FL) is the most common indolent and second most
common Non‐Hodgkins lymphoma (NHL) in the Western world. Standard treatment usually …

Clinical research examining the role of hematopoietic stem cell transplantation (SCT) in the
therapy of follicular non-Hodgkin lymphoma in adults is presented and critically evaluated in …

Autologous stem cell transplantation (SCT) is widely used as salvage treatment for patients
with relapsed follicular lymphoma (FL). Although SCT can induce prolonged remissions, it …

Although results of autologous stem cell transplantation (SCT) for recurrent follicular non-
Hodgkin lymphoma (NHL) have been previously reported, the long-term results and …